| Authors: |
Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, Grupo Español de Investigación en Cáncer de Mama (GEICAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Universidad Complutense, Madrid, Spain. Electronic address: mmartin@geicam.org., Holmes FA; Texas Oncology, Houston, TX, USA., Ejlertsen B; Rigshospitalet, Copenhagen, Denmark., Delaloge S; Institut Gustave Roussy, Villejuif, France., Moy B; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Iwata H; Aichi Cancer Center, Chikusa-ku, Nagoya, Japan., von Minckwitz G; Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neulsenburg, Germany., Chia SKL; BC Cancer Agency, Vancouver, BC, Canada., Mansi J; Guy's and St Thomas' Hospital National Health Service Foundation Trust and Biomedical Research Centre, King's College, London, UK., Barrios CH; Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil., Gnant M; Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria., Tomašević Z; Daily Chemotherapy Hospital, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Denduluri N; Virginia Cancer Specialists, Arlington, VA, USA., Šeparović R; University Hospital for Tumors, University Hospital Center 'Sestre milosrdnice', Zagreb, Croatia., Gokmen E; Ege University Faculty of Medicine, Izmir, Turkey., Bashford A; Auckland Hospital, Auckland, New Zealand., Ruiz Borrego M; Oncology Department, Hospital Universitario Virgen del Rocio, Seville, Spain., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Jakobsen EH; Department of Oncology, Lillebaelt Hospital, Vejle, Denmark., Ciceniene A; Oncology Institute of Vilnius University, Vilnius, Lithuania., Inoue K; Breast Oncology, Saitama Cancer Center, Kita-Adachi, Japan., Overkamp F; Oncologianova GmbH, Recklinghausen, Germany., Heijns JB; Department of Medical Oncology, Amphia Hospital, Breda, Netherlands., Armstrong AC; Department of Oncology, Christie Hospital Manchester, Manchester, UK., Link JS; Breastlink Medical Group Inc, Santa Ana, CA, USA., Joy AA; University of Alberta, Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada., Bryce R; Puma Biotechnology Inc, Los Angeles, CA, USA., Wong A; Puma Biotechnology Inc, Los Angeles, CA, USA., Moran S; Puma Biotechnology Inc, Los Angeles, CA, USA., Yao B; Puma Biotechnology Inc, Los Angeles, CA, USA., Xu F; Puma Biotechnology Inc, Los Angeles, CA, USA., Auerbach A; Puma Biotechnology Inc, Los Angeles, CA, USA., Buyse M; International Drug Development Institute, Louvain-la-Neuve, Belgium., Chan A; Breast Cancer Research Centre-Western Australia, Perth, WA, Australia; Curtin University, Perth, WA, Australia. |
